Popular searches: AAPL TSLA NVDA MSFT GOOGL

ZBIO Stock Price Prediction 2026

Zenas BioPharma, Inc. Common Stock

$18.37
$-2.51 (-12.02%)

AI-powered price predictions based on fundamental analysis and growth projections

Last Updated: January 30, 2026
🎯
AI TRADING RECOMMENDATION
Evaluate position
Key Signals:
  • ✓ MACD bullish crossover - upward momentum
  • • Volume showing accumulation (CMF: 0.3313)
MACD: Bullish | Volume: Accumulation
Fair Value Estimate
+89.8% Undervalued
Fair Value: $34.86 (Current: $18.37)

Based on PEG ratio analysis, this stock appears undervalued at current levels. The fair value estimate suggests 89.8% upside potential.

PEG Ratio
0.02
Attractive
Current P/E
2.61
Fair P/E
4.95
Earnings Growth
137.2%
📈

Volume Trend: Accumulation

Institutional Buying Detected - Smart money is accumulating shares

Chaikin Money Flow (CMF): 0.331
Money Flow Index (MFI): 63.1

Positive CMF indicates money flowing into the stock. This bullish signal suggests institutional interest.

Options Analysis: 1-Year Target Strategy

Score: 70/100

Analysis comparing options pricing vs AI growth projections. This helps identify if options are cheap (buy calls) or expensive (sell premium).

STRONG BUY - Excellent value, profitable at target
Wall Street Target
$43.57
+137.2% upside
Best Strike Found
$40.00
Exp: Dec. 18, 2026, midnight
Call Premium
$1.20
6.5% of stock price
Breakeven Price
$41.20
✓ Below target
Implied Probability
36.4%
Market's confidence
Value Score
100.0
Excellent buy
📈
POTENTIAL BUYING OPPORTUNITY
Options pricing suggests value relative to Wall Street analyst target

The $40 call expiring Dec 18, 2026 costs $1.20. If ZBIO reaches the Wall Street analyst target of $43.57, this option would be profitable with a 100.0% return.

Note: Options involve significant risk. Only invest what you can afford to lose.

Open Interest: 6 | Volume: 1
Data as of: Jan 30, 2026
How to Use This Analysis: Value Score shows profitability if the 1-year growth target is reached. Positive score = profitable for buyers. Negative score = profit opportunity for premium sellers (covered calls, credit spreads).
Price Targets by Timeframe
Based on Wall Street analyst consensus targets
Timeframe Target Price Potential Return
30 Days $20.39 +11.0%
90 Days $24.67 +34.3%
6 Months $30.97 +68.6%
1 Year $43.57 +137.2%

More ZBIO Analysis

Why is ZBIO Moving? Buy or Sell ZBIO? ZBIO Full Analysis ZBIO Trendline Analysis
ZBIO Price Prediction Trendline

Scenario Analysis (1-Year Outlook)

Bull Case
30% Probability
$54.46 (+196.5%)

Best case scenario if strong fundamentals and market conditions align

Base Case
50% Probability
$43.57 (+137.2%)

Expected scenario based on current growth trajectory

Bear Case
20% Probability
$30.50 (66.0%)

Downside scenario if market headwinds or disappointing results

Technical Indicators

RSI (14)
39.7
Neutral
MACD Signal
Bullish
Trend
Downtrend
Money Flow (CMF)
0.33

Key Fundamentals

P/E Ratio
2.61
P/S Ratio (TTM)
127.61x
High Premium
Market Cap
$1,914M
Analyst Target
$43.57
52-Week High
$20.11
52-Week Low
$18.37

Options Activity

Alert Score
85/100
Classification
Strong Alert
Unusual Activity
80.1
IV Spike
+84.9%

Recommendation: Strong unusual activity detected. Review for potential entry.

Investment Disclaimer: These price predictions are generated using AI models and historical data. They are not financial advice and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Buy or Sell Analysis Trendline Analysis Investment Advisor Options Advisor Options Chain & Analysis